Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA): A Targeted Antioxidant Strategy to Counter Oxidative Stress in Retinopathy
Antioxidants · 24.12.2024 · 14 (1) · 6
DOI: 10.3390/antiox14010006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 24.12.2024. Verfasst von Marco Zeppieri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Omega-3 fatty acids are critical components of cell membranes, including those in the retina. Specifically, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the primary omega-3 fatty acids that have been studied for their potential benefits in retinal health, preventing the progression of retinopathy. Several studies have shown that a higher intake of omega-3 fatty acids is associated with a lower risk of developing diabetic retinopathy and age-related macular degeneration (AMD). Reviewing clinical trials and observational studies that support the protective role of omega-3s in retinal disorders is essential. This comprehensive review aims to evaluate the current literature on the role of omega-3 fatty acids, exploring their mechanisms of action and anti-inflammatory, anti-angiogenic, and neuroprotective roles in the retina. Omega-3s have been shown to inhibit abnormal blood vessel growth in the retina, which is a significant factor in proliferative diabetic retinopathy and neovascular AMD. Furthermore, omega-3 fatty acids are often studied with other nutrients, such as lutein, zeaxanthin, and vitamins, for their synergistic effects on retinal health. Reviewing these combinations can help understand how omega-3s can be part of a comprehensive approach to preventing or treating retinopathies, especially in diabetic patients. This review emphasizes the preventive function of EPA and DHA in alleviating oxidative stress-related damage in retinal diseases, concentrating on their antioxidative mechanisms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy.
- Department of Medicine and Surgery, University of Enna "Kore", 94100 Enna, Italy.
- Mediterranean Foundation "G.B. Morgagni", 95125 Catania, Italy.
- Imperial College Ophthalmic Research Group (ICORG) Unit, Imperial College, 153-173 Marylebone Rd, London NW1 5QH, UK.
- Department of Neurosciences, Reproductive Sciences and Dentistry, University of Naples Federico II, 80131 Napoli, Italy.
- Department of Optometry, University of Benin, Benin City 300238, Edo State, Nigeria.
ORCID-Profile: Marco Zeppieri, Caterina Gagliano, Fabiana D'Esposito, Mutali Musa, Maria Sole Zanella, Federico Bernardo Rossi
Zitieren
APA
Zeppieri, M., Gagliano, C., D'Esposito, F., Musa, M., Gattazzo, I., Zanella, M. S., Rossi, F. B., Galan, A., & Babighian, S. (2024). Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA): A Targeted Antioxidant Strategy to Counter Oxidative Stress in Retinopathy. Antioxidants, 14(1), 6. https://doi.org/10.3390/antiox14010006
Vancouver
Zeppieri M, Gagliano C, D'Esposito F, Musa M, Gattazzo I, Zanella MS, et al. Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA): A Targeted Antioxidant Strategy to Counter Oxidative Stress in Retinopathy. Antioxidants. 2024;14(1):6. doi:10.3390/antiox14010006
BibTeX
@article{Zeppieri2024,
author = {Zeppieri, Marco and Gagliano, Caterina and D'Esposito, Fabiana and Musa, Mutali and Gattazzo, Irene and Zanella, Maria Sole and Rossi, Federico Bernardo and Galan, Alessandro and Babighian, Silvia},
title = {Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA): A Targeted Antioxidant Strategy to Counter Oxidative Stress in Retinopathy},
journal = {Antioxidants},
year = {2024},
volume = {14},
number = {1},
pages = {6},
doi = {10.3390/antiox14010006}
}
EUVIMED